… This review will discuss the roles of key cytokines in different stages of atherosclerosis. … of
the roles of cytokines in the cellular processes associated with atherosclerosis, the major focus …

… some cytokines and their key roles in atherosclerosis development they represent promising
therapeutic targets … An excellent example of cytokine therapeutics is a neutralizing antibody …

… When targeting inflammatory cytokines, some anti-atherosclerotic drugs are able to slow the
… atherosclerosis caused by lipid-lowering and reduces circulating inflammatory cytokines in …

Atherosclerosis, a chronic inflammatory disorder of the … that inhibition of a specific proinflammatory
cytokine (IL-1β) yielded … on targeting inflammation for atherosclerosis, focusing on …

Atherosclerosis (AS) features include progressive hardening and reduced elasticity of
arteries. AS is the leading cause of morbidity and mortality. An increasing amount of evidence …

… Atherosclerosis-related inflammation is mediated by a complex cocktail of pro-inflammatory
cytokines, … Both phospholipases are currently evaluated as promising therapeutic targets. …

… Upon activation within the atherosclerotic lesions or in secondary lymphoid organs, these
cells produce large amounts of pro-atherogenic cytokines that contribute to the growth and …

… Cytokines have previously been recognized as promising therapeutic targets for atherosclerosis,
and a … cytokines attenuates disease progression [3, 4], supporting the critical role of …

… that MSTFs represent promising therapeutic targets for the prevention of atherosclerosis. Due
… and IL-18, both proinflammatory cytokines involved in the atherosclerotic process, are also …

… type I transmembrane proteins, recognize specific signatures of the invading microbes and
activate a cascade of downstream signals inducing the secretion of inflammatory cytokines, …